Evidence map›Paper›PMID 42381037›Full record

ArticleCancer & metabolism2026

Fasting-mimicking diet counteracts gut microbial dysbiosis in experimental lynch syndrome.

Lorena Garcia-Castillo, Giulio Ferrero, Olga Blaževitš, Giulia Francescato, Azra Thaseen Eliass, Natalia E Cortez, Marc Beltrà, Sonia Tarallo, Barbara Pardini, Paola Costelli and 3 more

Abstract read
In one paragraph

Article in Cancer & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lorena Garcia-CastilloINSERM, MMG, Marseille Medical Genetics, Aix-Marseille University, Marseille, 13385, France.
Giulio FerreroDepartment Of Clinical and Biological Sciences, University of Torino, Turin, Italy.
Olga BlaževitšIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Giulia FrancescatoDepartment Of Clinical and Biological Sciences, University of Torino, Turin, Italy.
Azra Thaseen EliassDepartment Of Clinical and Biological Sciences, University of Torino, Turin, Italy.
Natalia E CortezDepartment Of Clinical and Biological Sciences, University of Torino, Turin, Italy.
Marc BeltràInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Sonia TaralloItalian Institute for Genomic Medicine (IIGM), C/O IRCCS Candiolo, Candiolo, Turin, Italy.
Barbara PardiniItalian Institute for Genomic Medicine (IIGM), C/O IRCCS Candiolo, Candiolo, Turin, Italy.
Paola CostelliDepartment Of Clinical and Biological Sciences, University of Torino, Turin, Italy.
Alessio NaccaratiItalian Institute for Genomic Medicine (IIGM), C/O IRCCS Candiolo, Candiolo, Turin, Italy.
Valter D LongoIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Fabio PennaDepartment Of Clinical and Biological Sciences, University of Torino, Turin, Italy. fabio.penna@unito.it.ORCID http://orcid.org/0000-0002-2774-6027

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of colorectal cancer (CRC) is largely influenced by hereditary factors, with up to one-third of cases linked to genetic predisposition. In parallel, environmental factors such as diet and intestinal microbiota play a significant role. Lynch syndrome (LS), the most common form of hereditary CRC, is due to mutations in DNA mismatch repair genes. Diet interventions such as calorie restriction (CR) can modify the course of the disease, altering nutrient supply and promoting beneficial microbial populations. Fasting-mimicking diets (FMD) are plant-based CR regimens that showed promise in modulating the gut microbiota and suppressing CRC progression in pre-clinical ectopic cancer models. In this study, Villin-Cre/Msh2-floxed (VCM) mice, modelling LS, were subjected to periodic FMD cycles for 10 months. FMD regimen influenced animal weight in a sexually dimorphic manner, stably reducing animal body weight only in males. Moreover, shotgun metagenomic sequencing revealed that FMD mitigated the dysbiotic longitudinal changes associated with cancer onset, preserving beneficial species, such as Lactobacillus johnsonii, and reducing adverse species, such as Escherichia coli. Metabolic pathway analysis also showed significant differences, with FMD preventing the upregulation of pathways involved in amino acid and nucleotide synthesis, potentially promoting tumour growth. Overall, the findings suggest that periodic FMD may result useful in a multimodal approach for LS management, counteracting gut microbiota alterations.

Indexed as

Colorectal cancerFasting-mimicking dietGut microbiota dysbiosisLynch syndromeMicrobial pathways

Identifiers

PMID42381037
PMCPMC13591788

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.